Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It was only last year that 737 felt like the number of scandals Boeing was embroiled in, rather than the name of its narrow-body aircraft.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The technology is garnering interest for its energy-saving benefits.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.
China is a top global producer of 30 of the 50 minerals the US considers critical, and is sources more than half of the US annual supply.
Banks pocketed huge sums in the first quarter from equities because the “increased market volatility” triggered a rush on transactions.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.